Training & Education

Training & Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

How would you treat a pregnant patient with type 2A von Willebrand disease?

This month Margaret V. Ragni, MD, MPH, discusses treatment options for a pregnant patient with type 2A von Willebrand disease. And don't forget to check out...
Oliver W. Press, MD, PhD

A Legacy of Mentorship

The American Society of Hematology (ASH) will honor the late Oliver (“Ollie”) W. Press, MD, PhD, with a 2017 Mentor Award at the 59th...

Paying it Forward

In this issue, we speak with Ronald Hoffman, MD, winner of a 2017 ASH Mentor Award. Dr. Hoffman is professor of medicine in hematology...

How I Treat in Brief: New Agents in Myeloma

This month, Philippe Moreau, MD, discusses the changing landscape of multiple myeloma (MM) therapeutics and options for treatment in frontline and relapsed settings. This material...

How would you treat an older patient with pancytopenia who was diagnosed with ALL?

This month Jonathan E. Kolitz, MD, discusses treating a patient with acute lymphocytic leukemia who is of advanced age. And don't forget to check out...

How should you treat a patient with lymphoma who developed “chemo brain” after R-CHOP...

This month, Carol S. Portlock, MD, discusses neurologic toxicity following R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). And don't forget to check out next month's clinical dilemma...

How I Treat in Brief: Double-Hit Lymphoma

This month, Jonathan W. Friedberg, MD, MMSc, discusses the diagnosis and treatment of patients with double-hit lymphoma. This material was repurposed from “How I Treat...

What are treatment options for a pregnant woman with iron deficiency who has had...

This month Michael Auerbach, MD, discusses treatment options for a pregnant woman with iron deficiency who has had bariatric surgery. And don't forget to check...

From ASH Meeting on Hematologic Malignancies: What is the prognosis for symptomatic, bulky FL...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: How would you use molecular diagnostic tests to...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...
Advertisement

Current Issue

January 2018, Volume 4, Issue 1

This issue features a look at the misconceptions that challenge the viability of the blood-banking system, highlights from the 2017 ASH Annual Meeting, and more.